Clinical Trials
31
Active:3
Completed:23
Trial Phases
2 Phases
Phase 3:5
Not Applicable:19
Drug Approvals
15
FDA:15
Drug Approvals
TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL Red Cell Preservative
- Approval Date
- Dec 11, 2019
FDA
TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1)
- Approval Date
- Dec 7, 2018
FDA
TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1)
- Approval Date
- Dec 7, 2018
FDA
TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1)
- Approval Date
- Dec 7, 2018
FDA
- Prev
- 1
- 2
- Next
Clinical Trials
Distribution across different clinical trial phases (24 trials with phase data)• Click on a phase to view related trials
Not Applicable
19 (79.2%)Phase 3
5 (20.8%)No trials found
News
MedHub-AI Receives PMDA Approval for AI-Powered Coronary Assessment Technology in Japan
MedHub-AI's AutocathFFR® becomes the first fully automated AI-powered software to receive PMDA approval in Japan for calculating Fractional Flow Reserve values directly from X-ray angiograms without invasive procedures.
Terumo Neuro Launches SOFIA Flow 88 Neurovascular Aspiration Catheter in EMEA Markets
Terumo Neuro announced the commercial availability of the SOFIA Flow 88 neurovascular aspiration catheter in Europe, Middle East, and Africa markets, expanding their stroke treatment portfolio.
FDA Approves Terumo Neuro's First-in-Class Dual-Layer Micromesh Carotid Stent System
Terumo Neuro has received FDA Premarket Approval for its innovative Carotid Stent System, marking the first dual-layer micromesh carotid stent approved for use in the United States.